Drug Topics

JULY 11, 2025

The Opportunities, Gaps in Diabetes Care Making Pharmacists Stand Out | ADA 2025 Brian Nowosielski ; Jon Easter, RPh July 4th 2025 Podcast Following his presentation at the American Diabetes Association’s 85th Scientific Sessions, Jon Easter caught up with Drug Topics to discuss the pharmacists’ role in diabetes management.

Specialty Pharmacies

Drug Topics

JULY 1, 2025

With federal reform continuously being punted along on Capitol Hill, state reform in places like Arkansas and Iowa may present hope for community pharmacies and patients with poor access to medications. “If

Community Pharmacies

Drug Topics

JULY 18, 2025

Researchers then summarized each article included in the review and presented the notable themes of each. Those terms included: patient, health, polypharmacy, ramification, and utilization.

Specialty Pharmacies

Drug Topics

JULY 10, 2025

The Opportunities, Gaps in Diabetes Care Making Pharmacists Stand Out | ADA 2025 Brian Nowosielski ; Jon Easter, RPh July 4th 2025 Podcast Following his presentation at the American Diabetes Association’s 85th Scientific Sessions, Jon Easter caught up with Drug Topics to discuss the pharmacists’ role in diabetes management.

Independent Pharmacies

Drug Topics

JULY 17, 2025

Key highlights from the conference include 2 innovative programs: SNPhA Speaks, which allows students to present their research and work, and a Social Determinants of Health certificate program. The convention will feature over 22 continuing education opportunities and 25 poster presentations.

Specialty Pharmacies

Drug Topics

JUNE 23, 2025

link] Recent Videos Related Content Pharmacist Outreach Reduces Therapeutic Inertia in T2D | ADA 2025 Killian Meara June 23rd 2025 Article Data presented at ADA’s 85th Scientific Sessions showed patients who received physician education with clinical pharmacist outreach had significantly better A1c levels at 6 months compared to usual care.

Compounding

Drug Topics

JULY 12, 2025

The Opportunities, Gaps in Diabetes Care Making Pharmacists Stand Out | ADA 2025 Brian Nowosielski ; Jon Easter, RPh July 4th 2025 Podcast Following his presentation at the American Diabetes Association’s 85th Scientific Sessions, Jon Easter caught up with Drug Topics to discuss the pharmacists’ role in diabetes management.

Community Pharmacies

Drug Topics

JULY 18, 2025

The Opportunities, Gaps in Diabetes Care Making Pharmacists Stand Out | ADA 2025 Brian Nowosielski ; Jon Easter, RPh July 4th 2025 Podcast Following his presentation at the American Diabetes Association’s 85th Scientific Sessions, Jon Easter caught up with Drug Topics to discuss the pharmacists’ role in diabetes management.

Specialty Pharmacies

Drug Topics

JULY 15, 2025

The Opportunities, Gaps in Diabetes Care Making Pharmacists Stand Out | ADA 2025 Brian Nowosielski ; Jon Easter, RPh July 4th 2025 Podcast Following his presentation at the American Diabetes Association’s 85th Scientific Sessions, Jon Easter caught up with Drug Topics to discuss the pharmacists’ role in diabetes management.

Insurance Coverage

Drug Topics

JULY 14, 2025

Currently it’s going to be slowing to upper single digits through the forecast period, basically because 2 of the leading drugs, there's immune checkpoint inhibitors—nivolumab is the molecule—and pembrolizumab is Keytruda, 2 of those are going off patent in 2028 and 2029. That trend is in the low-to-mid teens in terms of growth rate.

Immunization

Drug Topics

JULY 21, 2025

4 “This is a set of statistical, philosophy-of-science, and psychological principles which, we believe, is such as is demanded by the present scientific situation in the psychological and social sciences.” We call it ‘Q-methodology,’” wrote creator of the method William Stephenson.

Specialty Pharmacies

Drug Topics

JULY 17, 2025

The Opportunities, Gaps in Diabetes Care Making Pharmacists Stand Out | ADA 2025 Brian Nowosielski ; Jon Easter, RPh July 4th 2025 Podcast Following his presentation at the American Diabetes Association’s 85th Scientific Sessions, Jon Easter caught up with Drug Topics to discuss the pharmacists’ role in diabetes management.

Health and Personal Care Stores

Drug Topics

JUNE 11, 2025

The data from POETYK PsA-1 is being presented at the European Alliance of Associations for Rheumatology Congress, being held in Barcelona, Spain, from June 11 to 14. Additionally, a significantly greater proportion of patients who received the therapy did not have radiographic progression. References 1.

Specialty Pharmacies

Drug Topics

JUNE 18, 2025

In a session at the Pharmacy Quality Alliance Annual Meeting 2025, presenters stated that approximately 68% of patients have at least 1 unmet SDOH. Community pharmacies, which are very accessible to the public, are well positioned to address social determinants of health (SDOH), including food insecurity.

Communication

Pharmacy Times

JUNE 20, 2025

Prior to October 2024, the Advisory Committee on Immunization Practices (ACIP) recommended use of a PCV only for all adults aged 65 years and older, including those aged 19 to 64 years with risk conditions for pneumococcal disease.

Vaccines

Pharmacy Times

JULY 25, 2025

These data present a concerning reality in pneumococcal vaccine coverage, one that may have been exacerbated during the COVID-19 pandemic. According to 2022 data from a National Health Interview Survey of US adults ages 18 and older, just 23.0% of individuals ages 19 to 64 at increased risk for pneumococcal disease and 64.0%

Vaccines

Drug Topics

JULY 18, 2025

1 The company said approval of the new presentation was based on data that showed comparability between the new and existing version of the vaccine. The new vaccine presentation, which is approved for the same indications, will make the process easier because it does need to be reconstituted before giving it to a patient.

Vaccines

Pharmacy Times

JUNE 24, 2025

What I like about this conference is it's pharmacists pulling out the abstracts, it's pharmacists presenting the abstracts, and it's a panel discussion of that abstract by pharmacists. So it's ASCO from a pharmacist perspective. And I like that. It's disease-state focused.

Compounding Pharmacies

Drug Topics

JUNE 23, 2025

Experts Debate Diabetes Care in Community Pharmacy vs Health Systems Despite evidence of improved diabetes outcomes, all pharmacy settings are capable of having a significant impact on diabetes care, according to a presentation at the American Pharmacists Association (APhA) 2025 Annual Meeting and Exposition. Things are too serious.”

Community Pharmacies

Pharmacy Times

JULY 16, 2025

Hematologic malignancy presentations brought long-term evidence of benefit with Bruton tyrosine kinase (BTK) inhibitors and BCL2 combinations in chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) and promising early-phase results for T-cell engagers (TCEs) in myeloma and lymphoma.

HIV Treatment and Prevention Agents

Pharmacy Times

JULY 22, 2025

When you are enjoyable to work with, reliable, organized, and do impactful work, your name often comes up in spaces where you’re not present, opening doors to new partnerships. Strong collaborations lead to opportunities. It’s a cycle of trust and shared success, and I’ve been fortunate to benefit from and contribute to it.

Compounding Pharmacies

Pharmacy Times

JULY 2, 2025

Ototoxicity, presenting as tinnitus, hearing loss, dizziness, or vertigo, could occur and can be reversible or permanent. The study authors noted that sepsis is also a leading cause of death and hospitalization that often requires antibiotic administration.

FDA

Pharmacy Times

JUNE 20, 2025

She also discusses HOPA and its partnership with Pharmacy Times in providing cutting-edge information, expressing admiration for the Oncology Pharmacist Connect (OPC) conference's rapid dissemination of relevant information and high-quality presentations. Pharmacy Times : Can you discuss your career experience as an oncology pharmacist?

Compounding Pharmacies

Pharmacy Times

JULY 22, 2025

Compounding this issue, many pharmacies face ongoing staffing shortages, which hinder efficient operations and compromise the ability to deliver quality patient care. Overexpansion and staffing issues also play a role.

Mail-Order Pharmacies

Pharmacy Times

JUNE 24, 2025

In an interview with Pharmacy Times® , Gabe Hinojosa, PharmD, BCOP, clinical pharmacy specialist oncology/hematology at UT Southwestern, discussed the evolving treatment landscape for multiple myeloma (MM) and presented data from the 2025 American Society of Clinical Oncology Annual Meeting (ASCO).

Compounding Pharmacies

Pharmacy Times

JUNE 9, 2025

These conclusions were presented as part of an abstract from the open-label, phase 3 CheckMate 816 trial (NCT02998528) at the 2025 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois, and subsequently published in the Journal of Clinical Oncology.

Chemotherapy

Pharmacy Times

JUNE 27, 2025

Patients often present with peripheral blood, bone marrow, and splenic involvement. Leukemic nonnodal MCL , in contrast, originates from B cells that have undergone germinal center passage with somatic hypermutation in IGHV and that lack SOX11 expression. This subtype is associated with a more indolent course and genomic stability over time.

FDA

Drug Topics

JULY 17, 2025

The goal of the researchers’ study was to present the potential impact that pharmacist-led interventions and counseling can have for patients struggling with the condition. With pharmacist-led interventions and care increasingly on the rise, researchers explored them in the context of COPD management.

Specialty Pharmacies

Drug Topics

JULY 5, 2025

Kevin Cleveland, PharmD, professor at Idaho State University, explores the potential impacts of changes to the Advisory Committee on Immunization Practices (ACIP), highlighting concerns about shifting medical guidance and vaccine recommendations. Kevin Cleveland, PharmD: It's going to be pretty significant.

Patient Care

Pharmacy Times

JUNE 20, 2025

SHOW MORE When no contraindications are present, most cases can be managed well with nonsteroidal anti-inflammatory drugs. Pharmacists are essential in guiding treatment, identifying contraindications, and advising when further medical evaluation is needed.

Compounding Pharmacies

Pharmacy Times

JUNE 12, 2025

The increasing use of herbal supplements among patients undergoing cancer treatment, particularly those on oral therapies, presents a significant and often unaddressed challenge in oncology care.

Compounding Pharmacies

Pharmacy Times

JUNE 9, 2025

A retrospective study presented at the American Society of Health-System Pharmacists 2025 Pharmacy Futures meeting has revealed significant variability in asthma treatment regimens following initial diagnosis, with many patients not receiving care aligned with the Global Initiative for Asthma (GINA) recommendations.

Compounding Pharmacies

Pharmacy Times

JULY 12, 2025

4 Novak added that these services align well with appointment-based models and can be layered with immunizations, chronic disease monitoring, and medication therapy management. Addressing Barriers and Finding Solutions Despite the promise of these services, challenges remain.

Independent Pharmacies

Pharmacy Times

JUNE 25, 2025

Despite its proven efficacy, the conventional oral administration of lenalidomide presents challenges due to its short half-life and the high systemic exposure required to sustain therapeutic drug levels, which can lead to significant toxicities, particularly grade 3 or 4 hematologic adverse events (AEs).

Immunization

Pharmacy Times

JUNE 13, 2025

During the session “Collaborative Practice, Statewide Protocols, and Independent Prescriptive Authority: How Pharmacy is Expanding Services to Increase Access to Patients,” Klepser highlighted the importance of moving beyond product dispensing to provide higher-level services, such as immunizations and medication therapy management.

Compounding Pharmacies

Pharmacy Times

JUNE 16, 2025

1 The findings were presented at the Revolutionizing Atopic Dermatitis (RAD) 2025 conference held in Nashville, Tennessee. The results confirm nemolizumab’s use in increasing improvements in symptoms, such as itch and skin lesions, with prolonged treatment up to 2 years.

Compounding Pharmacies

Drug Topics

JULY 7, 2025

The Opportunities, Gaps in Diabetes Care Making Pharmacists Stand Out | ADA 2025 Brian Nowosielski ; Jon Easter, RPh July 4th 2025 Podcast Following his presentation at the American Diabetes Association’s 85th Scientific Sessions, Jon Easter caught up with Drug Topics to discuss the pharmacists’ role in diabetes management.

Compounding